PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment
Projects
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Pricing and Market Access
Events
Reports
Premium Insights
Excellence Awards
Magazine
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Accelerating Clinical Trials
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Future Pharma Services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment
Projects
Latest
Why is the healthcare industry hesitant to join the metaverse?
Illegal online pharmacies gain traction as regulators lag behind
After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Latest
AstraZeneca’s Ultomiris receives Japanese approval for NMOSD
Touchlight boosts DNA manufacturing capacity with latest expansion
After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
ICR and Royal Marsden NHS Foundation Trust open new integrated pathology unit
Sanofi deploys Veeva Systems’ solutions to improve quality management
Recursion plans $87.5m acquisitions to shore up AI drug discovery
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Who’s acquiring who? Immuno-oncology M&A activity in the pharmaceutical industry decreased by 8% in Q1 2023
Who’s acquiring who? Virtual care M&A activity in the pharmaceutical industry increased by 100% in Q1 2023
Who’s acquiring who? Orphan designated drugs M&A activity in the pharmaceutical industry decreased by 23% in Q1 2023
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Latest
Medicines adherence: Overcoming pharma’s biggest barrier to treatment success
Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective
Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective
Events
Reports
Premium Insights
PT
All articles by Gustav Ando
Gustav Ando
Pricing and Market Access
Why are pharma prices changing?
Pricing and Market Access
Mixed news on COVID19 vaccines: COVID-19 R&D tracker
Pricing and Market Access
Prices of essential COVID-19 medicines have increased 4% globally since February
Pricing and Market Access
US scrambles for resources in COVID-19 response
Pricing and Market Access
ISPOR Europe 2018 Barcelona
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Subscribe
Pricing and Market Access
Rapid changes in the global IRP environment
Pricing and Market Access
Nevermore ignore the role of digital health in health decision making
Pricing and Market Access
ISPOR 2018 Baltimore
Pricing and Market Access
Visit us at ISPOR 2017 Glasgow!
Pricing and Market Access
US Healthcare Reform: The ISPOR Debate
View more
Most Popular
FivepHusion collaborates with Treehill, Syneos for Deflexifol
Novavax receives positive opinion from CHMP for full MA of Covid vaccine
AstraZeneca’s Ultomiris receives Japanese approval for NMOSD